Dr. Kisor is Professor in the Department of Pharmaceutical and Biomedical Sciences at the Raabe College of Pharmacy at Ohio Northern University. Kisor received his Bachelor of Science degree in Pharmacy from the University of Toledo and his PharmD from The Ohio State University. He completed a fellowship in Therapeutic Drug Monitoring and Pharmacokinetics at Ohio State. Kisor came to ONU from Burroughs Wellcome Co., now GlaxoSmithKline, where he was a research scientist in Pharmacokinetics and Drug Metabolism, working mostly on the development of purine analogs, including the drug nelarabine, a derivative of guanine, one of the “building blocks of life,” that was marketed in the United States in 2005 and the European Union in 2007. His focus at ONU has been teaching pharmacogenetics and pharmacokinetics and relating genetics to kinetics. He has integrated pharmacogenetics into the pharmacokinetic subject matter since 1998. He is a member of the American Association of Colleges of Pharmacy (AACP), American Pharmacists Association, American Society of Health-System Pharmacists, and the National Coalition for Healthcare Provider Education in Genetics (NCHPEG), additionally, Kisor is a member of the Personalized Medicine Coalition (PMC) and is the advisor for the ONU Student Chapter of the PMC.
Fellowship: Therapeutic Drug Monitoring/Pharmacokinetics, The Ohio State University 1988
Pharm.D., The Ohio State University 1986
B.S. Pharmacy, University of Toledo 1984
Pharmacogenetics, Personalized Medicine, Pharmacokinetics
2009-2010 Innovations in Teaching Award
2007-2010 Mortar Board Favorite Professor Award
2002 Outstanding Professor Award
Clinical Applications of Pharmacogenomics
Kisor DF, Kane, MD, Talbot JT, Sprague JE. Pharmacogenetics, Kinetics and Dynamics for Personalized Medicine. 1st Ed. Jones and Bartlett Learning. Burlington, MA. 2013.
Benedict N, Kisor DF. The academic pharmacist in: Remington: The Science and Practice of Pharmacy. 22nd Ed. 2229-2234, 2013.
Kisor DF. Making personalized medicine an expectation of pharmacy students. Pers Med. 10(1):5-8, 2013.
Kisor DF. Collaboration to meet a therapeutic need: The development of nelarabine. Clin Med: Ther. 1:1317-1320, 2009.
Peer Reviewed Professional:
Kisor DF, Kroustos K. Pharmacogenomics: Implications for women’s health. U.S. Pharmacist. (in press).
Kisor DF, Sprague JE. The application of drug dosing guidelines based on preemptive genetic testing. Spec Pharm Times. 4(3), 2013.
Kisor DF, Munro C, Loudermilk E. Pharmacogenomics and the most commonly prescribed drugs of 2011. Pharm Times. 78(12), 2012.
Likovich M, Derr A, Kane M, Kisor DF, Sprague JE. Personalized medicine and the future of pharmacy practice. Pharm Times. 76(4), 2010.
Peer Reviewed Research/Reviews:
Shields KM, Sobota KF, Kroustos KR, Bright DR, North CL, Kisor DF. Implementation and evaluation of a student-led, online, longitudinal outpatient case elective. Curr Pharm Teach Learn. (in press).
Kisor DF, Talbot JN, Stockert AL, Smith A. Exploring a laboratory model of pharmacogenetics as applied to clinical decision making. Innov Pharm. 4(2);1-12, 2013.